Recent Finacing
Recent Raise
EnBiotix is a bioengineering company developing inhaled antibiotics and potentiators, including ColiFin, inhaled murepavidin, EBX-001, EBX-002, and engineered bacteriophage EPP-001 for respiratory, UTI and prosthetic-joint infections.
